Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Apple TVs 77th Annual Primetime Emmy Awards Party - LA

Devin Kawaoka arrives at Apple TV+'s 77th Annual Primetime Emmy Awards Party held at Ysabel on September 14, 2025 in West Hollywood, Los Angeles, California, United States. Photo by Xavier Collin/Image Press Agency/ABACAPRESS.COM

E

Apple TVs 77th Annual Primetime Emmy Awards Party - LA

Devin Kawaoka arrives at Apple TV+'s 77th Annual Primetime Emmy Awards Party held at Ysabel on September 14, 2025 in West Hollywood, Los Angeles, California, United States. Photo by Xavier Collin/Image Press Agency/ABACAPRESS.COM

E

Shrinking Season 2 Premiere - LA

Devin Kawaoka arrives at the World Premiere Of Apple TV+ Series' 'Shrinking' Season 2 held at the Pacific Design Center on October 8, 2024 in West Hollywood, Los Angeles, California, United States. Photo by Xavier Collin/Image Press Agency/ABACAPRESS.COM

E

Shrinking Season 2 Premiere - LA

Devin Kawaoka arrives at the World Premiere Of Apple TV+ Series' 'Shrinking' Season 2 held at the Pacific Design Center on October 8, 2024 in West Hollywood, Los Angeles, California, United States. Photo by Xavier Collin/Image Press Agency/ABACAPRESS.COM

E

Shrinking Season 2 Premiere - LA

Devin Kawaoka arrives at the World Premiere Of Apple TV+ Series' 'Shrinking' Season 2 held at the Pacific Design Center on October 8, 2024 in West Hollywood, Los Angeles, California, United States. Photo by Xavier Collin/Image Press Agency/ABACAPRESS.COM

E

Shrinking Season 2 Premiere - LA

Devin Kawaoka, Michael Urie At World Premiere Of Apple TV+ "Shrinking" Season 2 at Pacific Design Center in West Hollywood, CA, USA on October 08 2024. Photo by Fati S/ABACAPRESS.COM

E

Shrinking Season 2 Premiere - LA

Devin Kawaoka At World Premiere Of Apple TV+ "Shrinking" Season 2 at Pacific Design Center in West Hollywood, CA, USA on October 08 2024. Photo by Fati S/ABACAPRESS.COM

E

Shrinking Season 2 Premiere - LA

Devin Kawaoka At World Premiere Of Apple TV+ "Shrinking" Season 2 at Pacific Design Center in West Hollywood, CA, USA on October 08 2024. Photo by Fati S/ABACAPRESS.COM

E

Shrinking Season 2 Premiere - LA

Devin Kawaoka At World Premiere Of Apple TV+ "Shrinking" Season 2 at Pacific Design Center in West Hollywood, CA, USA on October 08 2024. Photo by Fati S/ABACAPRESS.COM

E

Shrinking Season 2 Premiere - LA

Devin Kawaoka At World Premiere Of Apple TV+ "Shrinking" Season 2 at Pacific Design Center in West Hollywood, CA, USA on October 08 2024. Photo by Fati S/ABACAPRESS.COM

E

WHO recommends full publication of avian flu studies

GENEVA, Switzerland - Yoshihiro Kawaoka (L), a professor of the Institute of Medical Science at the University of Tokyo, and Masato Tashiro from Japan's National Institute of Infectious Diseases, hold a press conference in Geneva on Feb. 17, 2012. The World Health Organization recommended the same day that two reports on avian flu studies by Japanese and European researchers, including one by the University of Tokyo institute, be published in full. A U.S. government panel had called on two leading scientific journals not to print them completely over fears that detailed information about the lethal virus could be used in bioterrorism. Kawaoka called the WHO recommendation a ''reasonable conclusion.''

E

Prof. Yotsuyanagi and Prof. Kawaoka of the University of Tokyo announcing the phase I clinical trial of iEvac-Z

Professor Hiroshi Yotsuyanagi, Professor Yoshihiro Kawaoka and their colleagues at the Institute of Medical Science, the University of Tokyo announced on April 5 that they will start Phase I clinical trials of the Ebola vaccine "iEvac-Z" at the hospital affiliated with the Institute this month. iEvac-Z is an inactivated vaccine made from mutant Ebola virus that lacks some of its genes. iEvac-Z is an inactivated vaccine produced from a mutant Ebola virus that lacks some of its genes, and is expected to be highly safe. The research team created a mutant virus that lacks the gene that makes VP30, a protein essential for the multiplication of the Ebola virus. Professor Yotsuyanagi said, "We can assume that there are side effects such as serious allergic symptoms that may occur in general, but nothing specific to iEvac-Z has been reported yet. We are planning to use it on people who are at high risk of infection" he explained. (= December 5, 2019, photo credit: Nikkan Kogyo Shimbun / Kyodo News Images)

E

WHO recommends full publication of avian flu studies

GENEVA, Switzerland - Yoshihiro Kawaoka (L), a professor of the Institute of Medical Science at the University of Tokyo, and Masato Tashiro from Japan's National Institute of Infectious Diseases, hold a press conference in Geneva on Feb. 17, 2012. The World Health Organization recommended the same day that two reports on avian flu studies by Japanese and European researchers, including one by the University of Tokyo institute, be published in full. A U.S. government panel had called on two leading scientific journals not to print them completely over fears that detailed information about the lethal virus could be used in bioterrorism. Kawaoka called the WHO recommendation a ''reasonable conclusion.'' (Kyodo)